Request Deal Involvement

MorphoSys to acquire Constellation Pharmaceuticals for $1.7bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Wachtell Lipton Rosen & Katz

legal advisors

Wachtell Lipton Rosen & Katz

Centerview Partners

financial advisors

Centerview Partners

Willkie Farr & Gallagher

legal advisors

Willkie Farr & Gallagher

Gibson Dunn & Crutcher

legal advisors to financial advisors

Gibson Dunn & Crutcher

Sard Verbinnen & Co

pr advisors

Sard Verbinnen & Co

Skadden Arps Slate Meagher & Flom

legal advisors

Skadden Arps Slate Meagher & Flom

Joele Frank

pr advisors

Joele Frank

Goldman Sachs

financial advisors

Goldman Sachs

Freshfields Bruckhaus Deringer

legal advisors to financial advisors

Freshfields Bruckhaus Deringer

Goodwin Procter

legal advisors

Goodwin Procter

or

Principals

CONSTELLATION PHARMACEUTICALS

target

CONSTELLATION PHARMACEUTICALS

MORPHOSYS AG

bidder

MORPHOSYS AG

ROYALTY PHARMA

bidder

ROYALTY PHARMA

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite